Plain-English translation of NCT05041140 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This research study is testing a new imaging technology called hyperpolarized xenon MRI (a specialized breathing scan) to measure how well the lungs are working in people who have received a bone marrow transplant. Researchers want to see if this new scan can better detect lung problems compared to standard breathing tests and CT scans. The goal is to help doctors catch and treat lung complications earlier in transplant patients.
After a bone marrow transplant, some patients develop serious lung problems that are hard to detect with standard tests. This new imaging technology may be able to spot these problems sooner and more accurately, which could help doctors treat patients before the damage becomes severe.
You likely qualify if…
You likely don't qualify if…
If you qualify, you would come to MD Anderson for a specialized lung imaging scan called hyperpolarized xenon MRI, which is similar to a regular MRI but uses xenon gas to create detailed pictures of how your lungs work. You would also have standard breathing tests and possibly a CT scan. The study will follow you for 6 months to see if the new imaging helps predict lung problems. Healthy volunteers may also be recruited just to help calibrate the new scanning technology.
AI-generated summary from trial data · Sep 3, 2026 · Not medical advice
United States